Dr. Reddy’s gets USFDA approval for anti-cancer injection
Dr. Reddy’s has received an approval from US Food and Drug Administration (USFDA) for the launch of Doxorubicin Hydrochloride Liposome […]
Lupin launches Ortho-Cyclen tablets in US
Lupin Limited has launched its Norgestimate and Ethinyl Estradiol Tablets USP, 0.25 mg/0.035 mg having received approval from the United […]
Harvard study – Exclusive market rights encouraging high drug prices
In a remarkable Harvard Study, the key reasons behind the high drug prices in the United States (US) have been […]
Indoco Remedies to Acquire Piramal Enterprises Clinical Research Business
Indoco Remedies Limited “ a firm that makes both finished drugs and drug ingredients for export across 35 countries – […]
Government to Revamp Jan Aushadhi Scheme
The government has decided to revamp the ‘Jan Aushadhi’ scheme which seeks to provide quality medicine at affordable price. Out […]
Himachal to get generic medicine stores
The state government will open generic medicine stores in two medical colleges inHimachal Pradeshon a pilot basis, state Health and […]
Two Indian Healthcare Companies Jointly Steps in M&A Deals
US-based generic drug maker Mylan Inc is going to pay USD 1.6 billion plus potential additional consideration of up to […]
IMA, MCI differ over generic drugs
IMA is against the new directive of the MCI which mandates heads of medical colleges, hospitals and its state chapters prescribe medicines only in generic terms
Kerala Goes for Free Generic Drugs
From 1st November, doctors in Kerala will only prescribe generic drugs. Patients in government medical colleges and hospitals in Thiruvananthapuram, […]
Strides Acrolab Gets FDA Approval for Generic Cancer Drug
Indian drug firm Strides Arcolab has received USFDA approval for the generic Fluorouracil Injection which will be used to treat […]
Ranbaxy may dilute 60% in new R&D unit
Ranbaxy Laboratories may dilute up to 60% stake in its new research company, which will be formed by hiving off its R&D unit into a separate entity in 2008.
